Ultrahigh-field cardiovascular magnetic resonance T1 and T2 mapping for the assessment of anthracycline-induced cardiotoxicity in rat models: validation against histopathologic changes

Ultrahigh-field cardiovascular magnetic resonance T1 and T2 mapping for the assessment of anthracycline-induced cardiotoxicity in rat models: validation against histopathologic changes

Abstract Background Chemotherapy-induced cardiotoxicity is a well-recognized adverse effect of chemotherapy. Quantitative T1-mapping cardiovascular magnetic resonance (CMR) is useful for detecting subclinical myocardial changes in anthracycline-induced cardiotoxicity. The aim of the present study wa...

Full description

Bibliographic Details
Main Authors:	Heae Surng Park, Yoo Jin Hong, Kyunghwa Han, Pan Ki Kim, Eunkyung An, Ji Yeon Lee, Chul Hwan Park, Hye-Jeong Lee, Jin Hur, Young Jin Kim, Byoung Wook Choi
Format:	Article
Language:	English
Published:	BMC 2021-06-01
Series:	Journal of Cardiovascular Magnetic Resonance
Subjects:	Magnetic resonance imaging Myocardial fibrosis Edema Inflammation T1 mapping Cardiotoxicity
Online Access:	https://doi.org/10.1186/s12968-021-00767-8

Similar Items

Dexrazoxane in anthracycline cardiotoxicity
by: Abhijit S Nair
Published: (2017-01-01)

Anthracycline Cardiotoxicity
by: Umberto Campia, MD, MSc, et al.
Published: (2020-06-01)

Cardiotoxicity of Anthracyclines
by: Daniela Cardinale, et al.
Published: (2020-03-01)

Anthracycline-Induced Cardiotoxicity
by: Radomír Hrdina, et al.
Published: (2000-01-01)

Anthracycline-Induced Cardiotoxicity
by: Jennifer E. Liu, MD
Published: (2020-03-01)

Cardiotoxicity evaluation using magnetic resonance imaging in breast Cancer patients (CareBest): study protocol for a prospective trial
by: Yoo Jin Hong, et al.
Published: (2020-06-01)

Updates in Anthracycline-Mediated Cardiotoxicity
by: Canan G. Nebigil, et al.
Published: (2018-11-01)

POSSIBILITY OF DRUG PREVENTION ANTHRACYCLINE-INDUCED CARDIOTOXICITY
by: V. I. Chernov, et al.
Published: (2016-02-01)

Risk Factors for Anthracycline-Induced Cardiotoxicity
by: Shuo Qiu, et al.
Published: (2021-09-01)

Early Detection and Serial Monitoring of Anthracycline-Induced Cardiotoxicity Using T1-mapping Cardiac Magnetic Resonance Imaging: An Animal Study
by: Yoo Jin Hong, et al.
Published: (2017-06-01)

Detection of Subclinical Anthracyclines' Cardiotoxicity in Children with Solid Tumor
by: Hui-Min Hu, et al.
Published: (2018-01-01)

Assessment of anthracycline-induced long-term cardiotoxicity in patients with hematological malignancies
by: Aws Sabah Al-Rubaye, et al.
Published: (2019-01-01)

Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer
by: Ariane V.S. Macedo, MD, MSc, et al.
Published: (2019-09-01)

MODERN VIEW ON CARDIOTOXICITY OF CHEMOTHERAPEUTICS IN ONCOLOGY INCLUDING ANTHRACYCLINES
by: G. E. Gendlin, et al.
Published: (2017-03-01)

The cardioprotective effects of probucol against Anthracycline and Trastuzumab mediated cardiotoxicity
by: Walker, Jonathan Robert
Published: (2010)

The cardioprotective effects of probucol against Anthracycline and Trastuzumab mediated cardiotoxicity
by: Walker, Jonathan Robert
Published: (2010)

Anthracycline induced cardiotoxicity: biomarkers and “Omics” technology in the era of patient specific care
by: Shayan Moazeni, et al.
Published: (2017-05-01)

Clinical and preclinical evidence of sex-related differences in anthracycline-induced cardiotoxicity
by: Becky Meiners, et al.
Published: (2018-08-01)

Tissue Doppler Imaging for anthracycline cardiotoxicity monitoring in pediatric patients with cancer
by: Francesco Venturelli, et al.
Published: (2018-09-01)

Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
by: Neha Bansal, et al.
Published: (2019-12-01)

Modeling anthracycline-induced cardiotoxicity with patient-specific iPSCs
by: Haupt, Luis Peter
Published: (2018)

Mechanisms of Anthracycline-Induced Cardiotoxicity: Is Mitochondrial Dysfunction the Answer?
by: Alessandra Murabito, et al.
Published: (2020-03-01)

Structural and Electrophysiological Changes in a Model of Cardiotoxicity Induced by Anthracycline Combined With Trastuzumab
by: Claudia Altomare, et al.
Published: (2021-04-01)

The effects of an insulin-glucose-potassium (IGK) pretreatment on the bupivacaine cardiotoxicity
by: Jin-Tae Kim, et al.
Published: (2013-01-01)

Anthracycline-associated cardiotoxicity in adults: systematic review on the cardioprotective role of beta-blockers
by: Roberto Ramos Barbosa, et al.

Protective Effects of ω-3 PUFA in Anthracycline-Induced Cardiotoxicity: A Critical Review
by: Simona Serini, et al.
Published: (2017-12-01)

Cardiac computed tomography-derived extracellular volume fraction in late anthracycline-induced cardiotoxicity
by: Koichi Egashira, et al.
Published: (2021-06-01)

Upfront dexrazoxane for the reduction of anthracycline-induced cardiotoxicity in adults with preexisting cardiomyopathy and cancer: a consecutive case series
by: Sarju Ganatra, et al.
Published: (2019-01-01)

Anthracycline cardiomyopathy
by: Vasiliy Nefedovich Anokhin, et al.
Published: (2011-10-01)

Beta-blockers for the primary prevention of anthracycline-induced cardiotoxicity: a meta-analysis of randomized controlled trials
by: Yingxu Ma, et al.
Published: (2019-04-01)

Translational Proteomics Analysis of Anthracycline-Induced Cardiotoxicity From Cardiac Microtissues to Human Heart Biopsies
by: Nhan Nguyen, et al.
Published: (2021-06-01)

Efficacy of Physical Exercise to Offset Anthracycline‐Induced Cardiotoxicity: A Systematic Review and Meta‐Analysis of Clinical and Preclinical Studies
by: Willeke R. Naaktgeboren, et al.
Published: (2021-09-01)

High Density Lipoprotein and Its Precursor Protein Apolipoprotein A1 as Potential Therapeutics to Prevent Anthracycline Associated Cardiotoxicity
by: George E. G. Kluck, et al.
Published: (2020-04-01)

The role of the Tei index in assessing for cardiotoxicity from anthracycline chemotherapy: a systematic review
by: Sadie Bennett, et al.
Published: (2021-05-01)

Early Detection and Prediction of Anthracycline-Induced Right Ventricular Cardiotoxicity by 3-Dimensional Echocardiography
by: Rui Zhao, MBBS, et al.
Published: (2020-03-01)

Evaluation of subclinical cardiotoxicity in patients with breast cancer and arterial hypertension in two regimens of anthracycline-containing chemotherapy
by: A A Avalyan, et al.
Published: (2018-12-01)

Bioinformatic analysis of peripheral blood miRNA of breast cancer patients in relation with anthracycline cardiotoxicity
by: Wang Yadi, et al.
Published: (2020-02-01)

Anthracycline-induced cardiotoxicity : the role of proteolytic pathways
by: Sishi, Balindiwe J. N. (Balindiwe Jennifer Nonkosazana)
Published: (2012)

Rationale, Design, and Feasibility of a Prospective Multicenter Registry Study of Anthracycline-Induced Cardiotoxicity (AIC Registry)
by: Keiko Inoue, et al.
Published: (2021-03-01)

Cardiotoxicity Complication of Radiotherapy
by: Beta Agustia Wisman, et al.
Published: (2017-12-01)